Home Search
Epidyolex - search results
If you're not happy with the results, please do another search
Epidyolex Receives European Commission Approval
GW Pharmaceuticals has announced it has received marketing authorisation for Epidyolex (not a typo) for treating certain conditions in all 28 EU countries as...
TGA Medical Cannabis Approvals Update
Figures from Australia's Therapeutic Goods Administration indicate the agency is being kept busy with SAS Category B approvals for medicinal cannabis.
Australia's Special Access Scheme...
New GW Pharma Facility Construction Kicks Off
GW Pharmaceuticals' parent has announced construction of a new major cannabinoid manufacturing facility at the UK's Kent Science Park has commenced.
GW Pharma is the...
Australia’s Emyria Readies For CBD Trial
Another Australian company eyeing the country's low-dose, prescription-free cannabidiol market is clinical-stage biotech company Emyria Limited (ASX: EMD).
Last year we reported Australia’s Cann Group...
CBD Medicine Given TSC Green Light In The UK
Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...
More Cash For Australian Medical Cannabis Research
The Australian Federal Government's recently handed down 2021-22 Budget included $1.5 million for a trial exploring personalised medicinal cannabis dosing in cancer patients.
Awarded via...
GW Pharma Receives Queen’s Award For Cannabinoid Work
In what may be a first for a medical cannabis company, GW Pharmaceuticals has received the Queen’s Award for Enterprise 2021 in the Innovation...
Jazz Pharmaceuticals To Acquire GW Pharma
Jazz Pharmaceuticals is to acquire cannabinoid medicine manufacturer GW Pharmaceuticals for a whopping sum.
Founded in 1998, GW Pharmaceuticals manufactures CBD-based Epidiolex, which is marketed...
Epidiolex A Cash Machine For GW Pharmaceuticals
GW Pharmaceuticals estimates its net product sales for 2020 to have reached approximately USD $526 million - and its cannabidiol medicine made up the...
Cannabidiol CO2 Extraction Patent Action Launched
Canada's Canopy Growth is taking on the UK's GW Pharmaceuticals over a widely used cannabidiol extraction method.
The company recently filed its complaint in the...
Advertisement
